Related Experiment Video
Updated: Mar 1, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
pH-Sensitive drug delivery system based on hydrophobic modified konjac glucomannan
Jinling Luan1, Kao Wu1, Cao Li2
1Glyn O. Philips Hydrocolloid Research Centre at HUT, Hubei University of Technology, Wuhan 430068, PR China.
Amphiphilic konjac glucomannan (KGM) micelles were developed for targeted drug delivery. These pH-responsive micelles efficiently load and release curcumin, showing promise for cancer therapy and intracellular drug delivery applications.
Area of Science:
- Biomaterials Science
- Drug Delivery
- Nanotechnology
Background:
- Konjac glucomannan (KGM) is a natural polysaccharide with biocompatible properties.
- Developing efficient intracellular drug delivery systems is crucial for effective cancer therapy.
- Stimuli-responsive materials offer enhanced control over drug release kinetics.
Purpose of the Study:
- To synthesize and characterize amphiphilic konjac glucomannan-grafted aliphatic amine (KGM-g-AH) micelles.
- To investigate the potential of these micelles for acid-triggered curcumin release.
- To evaluate the safety, biocompatibility, and cellular uptake of KGM-g-AH micelles for intracellular drug delivery.
Main Methods:
- Two-step synthesis utilizing Schiff's base formation for KGM modification.
- Preparation and characterization of KGM-g-AH micelles, including size and stability analysis.
- In vitro studies on curcumin loading, release kinetics, pH-responsiveness, cytotoxicity, and cellular uptake.
Main Results:
- KGM-g-AH micelles were successfully synthesized, with KGM-g-AH8 forming stable spherical nano-micelles (107.6±11.6nm).
- These micelles demonstrated high curcumin loading capacity and good physical stability over 28 days.
- In vitro studies confirmed controlled release, endosomal/lysosomal pH responsiveness, intracellular pH-sensitivity, safety, and biocompatibility.
Conclusions:
- KGM-based micelles are feasible and promising strategies for cancer therapy.
- The developed micelles offer new potential options for intracellular drug delivery.
- The Schiff's base linkage provides an effective "switch" for acid-triggered drug release.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed I
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Oral Drug Delivery Systems: Delayed-Release Systems
Oral Drug Delivery Systems: Continuous-Release Systems

